Evidence map›Paper›PMID 41021116›Full record

ArticleAlcohol, clinical & experimental research2025

Early alcohol abstinence symptoms and the role of cumulative adversity.

Helen C Fox, Jorge Alcina, Scott M Hyman, Verica Milivojevic, Rajita Sinha

Abstract read
In one paragraph

Article in Alcohol, clinical & experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Early alcohol abstinence symptoms and the role of cumulative adversity.Alcohol, clinical & experimental research · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Helen C FoxDepartment of Psychiatry, Yale School of Medicine, Yale Stress Center, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0002-3607-439X
Jorge AlcinaClinical Psychology Program, Miami Campus, Albizu University, Miami, Florida, USA.
Scott M HymanClinical Psychology Program, Miami Campus, Albizu University, Miami, Florida, USA.
Verica MilivojevicDepartment of Psychiatry, Yale School of Medicine, Yale Stress Center, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0001-6752-2223
Rajita SinhaDepartment of Psychiatry, Yale School of Medicine, Yale Stress Center, New Haven, Connecticut, USA.

Funding

Effect of Prazosin on Alcohol Craving, Stress Dysregulation and Alcohol RelapseR01AA020504 · NIAAA · YALE UNIVERSITY · PI FOX, HELEN CECILIA, SINHA, RAJITA · 2012 to 2016
$2.7M
Chronic Alcohol, Stress Inflammatory Response and Relapse RiskR01AA020095 · NIAAA · YALE UNIVERSITY · PI FOX, HELEN CECILIA, SINHA, RAJITA · 2011 to 2015
$1.7M
Guanfacine to reduce relapse risk in women with alcohol use disorder (AUD)R21AA024880 · NIAAA · STATE UNIVERSITY NEW YORK STONY BROOK · PI FOX, HELEN CECILIA · 2017 to 2018
$417k
Stress system changes in alcoholics with and without depressive symptomatologyR03AA022500 · NIAAA · YALE UNIVERSITY · PI FOX, HELEN CECILIA · 2013 to 2014
$140k
HRSA HHS D40HP33382NIAAA NIH HHS R01 AA020095NIAAA NIH HHS R01 AA020504NIAAA NIH HHS R03 AA022500NIAAA NIH HHS R21 AA024880NIH HHS R01AA20095NIH HHS R01AA20504NIH HHS R03AA022500NIH HHS R21AA024880
6 · The paper itself

Abstract

backgroundThis study examined the course of early alcohol abstinence symptoms across multiple clinical domains (i.e., cravings, withdrawal, mood, and cardiovascular measures) in individuals undergoing inpatient alcohol treatment and assessed whether cumulative lifetime adversity influences the severity and trajectory of these symptoms.

methodsResearchers tracked withdrawal symptoms, alcohol cravings, mood states, heart rate, and blood pressure in 34 inpatient participants at treatment admission and weekly for three to four consecutive weeks. The analysis employed two approaches: first, examining symptom presentation and progression over time in alcohol-dependent individuals using cumulative adversity as a moderating variable; second, comparing symptom patterns between alcohol-dependent participants with high versus low lifetime adversity against 38 control participants at each timepoint.

resultsAbstinence symptoms resolved by the third week of inpatient treatment across all participants. However, alcohol-dependent individuals with greater lifetime adversity exhibited significantly more severe symptom patterns compared to alcohol-dependent individuals with fewer adverse experiences. These differences persisted even when controlling for recent alcohol and tobacco use severity over the preceding 3 months.

conclusionsUnderstanding the profile and progression of early abstinence symptoms, along with stress-related moderating factors, could inform more personalized care planning. Cumulative lifetime adversity may serve as a readily measurable correlate of early abstinence severity and may be valuable for predicting alcohol treatment outcomes. Addressing the effects of cumulative lifetime adversity may serve as a target for early intervention in patients with alcohol use disorder.

Indexed as

Alcohol AbstinenceAlcoholismSubstance Withdrawal SyndromeAdultAffectBlood PressureCravingFemaleHeart RateHumansMaleMiddle Agedalcohol cravingcardiovascularcumulative adversityearly abstinencemood

Identifiers

PMID41021116
PMCPMC12519049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.